Blueprint MedTech Cycle 2 Annoucement - CIMIT MAIN
Initiatives
Funding Opportunity: Blueprint MedTech Spring Award Competition
CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, have started accepting pre-proposals from academic and industry applicants who have emerging technologies that aim to improve the prevention, diagnosis, and/or treatment of disorders involving the nervous system or consequences of such a disease or injury.
Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization.
A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space.
Program Details:
- Awards up to $500K to help support development toward commercialization
- Mentorship from experienced medtech commercialization experts
- Support to address business, regulatory, clinical, and technical project areas
The deadline for this opportunity has passed.
News and Events
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Test Enables Single-Visit Testing and Treatment for Hepatitis C
Read More
»
Connect with Us
Our Lasting Impact
As an early pioneer in managing translational research, Cimit has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.
We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.
We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.